Increased bids for Sensidose

Increased bids for Sensidose

The takeover bids for Sensidose continue to increase and the valuation has now reached SEK 100 million. At the end of last week, EQL announced...

27th April 2023
Good start for life science M&A in 2023

Life science business rate gives hope for recovery

The major pharmaceutical companies have opened their wallets at the beginning of 2023 – at least when compared to the previous year. The business volume...

26th April 2023
New takeover bid for Sensidose

New takeover bid for Sensidose

Parkinson's disease company Sensidose is emerging as a hot acquisition candidate in the life sciences sector. In March, BioStock reported that Norwegian Navamedic...

21th April 2023
Sensidose's CEO on the offer from Navamedic

Sensidose's share rises after bid from Navamedic

Sensidose develops and sells individualized dosing of drugs for the medical treatment of Parkinson's disease. The pharmaceutical company is in a...

March 30, 2023
Sensidose is growing

Sensidose is growing and seeing new opportunities in Finland

Pharmaceutical company Sensidose is growing and seeing new opportunities in new markets. According to yesterday's year-end report, sales increased by 10,9 percent in existing...

February 17
Sensidose Deputy CEO Philip Slätis

Sensidose's vice president in 100 days on the job

Philip Slätis

February 8
Sensidose expects sales growth despite drop in Q3

Sensidose declines in Q3 but expects sales growth

Spotlight-listed Sensidose reports progress on several fronts in the third quarter, despite component shortages and some other challenges. During the quarter,...

November 15
Sensidose

Congress in Poland paves the way for Sensidose

Sensidose recently participated in the Polish Neurological Society's annual scientific and educational conference in Lublin. An increased presence is a strategic step...

September 28
Sensidose

Sensidose's founder talks about the company's journey

The idea for the Sensidose treatment strategy came about in the mid-1990s when professors Sten-Magnus Aquilonius and Christer Nyström realized...

September 12
Sensidose

Sensidose recruits vice president ahead of expansion

Pharmaceutical company Sensidose has recruited Philip Slätis as Chief Operating Officer and Vice President, effective November 1. With broad...

September 6
Sensidose

Continued positive sales development for Sensidose

Sensidose recently published its second quarter report, reporting a 21 percent sales increase compared to the same quarter in 2021....

August 26
Sensidose

Sensidose's CEO looks to the fall after strong growth

Sensidose enters the first half of the year with strong cash flow after listing on Spotlight and rising sales despite component shortages. In addition,...

July 7